SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-012755
Filing Date
2016-04-29
Accepted
2016-04-29 16:54:47
Documents
4
Period of Report
2016-06-28
Effectiveness Date
2016-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228493zdef14a.htm DEF 14A 794068
2 G355115.JPG g355115.jpg GRAPHIC 18056
3 G38359.JPG g38359.jpg GRAPHIC 5022
4 G769555.JPG g769555.jpg GRAPHIC 5763
  Complete submission text file 0001047469-16-012755.txt   835370
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34921 | Film No.: 161607713
SIC: 2834 Pharmaceutical Preparations